Cargando…

Expression of Concern: A new method for ethical and efficient evidence generation for off-label medication use in oncology (a case study in glioblastoma)

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10426282/ https://www.ncbi.nlm.nih.gov/pubmed/37587985 http://dx.doi.org/10.3389/fphar.2023.1264737

Ejemplares similares

A New Method for Ethical and Efficient Evidence Generation for Off-Label Medication Use in Oncology (A Case Study in Glioblastoma)
por: Agrawal, Samir, et al.
Publicado: (2019)

Factors Associated With Off-Label Oncology Prescriptions: The Role of Cost and Financing in a Universal Healthcare System
por: Gordon, Noa, et al.
Publicado: (2021)

The Off-Label Use of Antineoplastics in Oncology Is Limited But Has Notable Scientific Support in a University Hospital Setting
por: Herrero Fernandez, Marta, et al.
Publicado: (2019)

Off-Label Use of Antineoplastic Drugs to Treat Malignancies: Evidence From China Based on a Nationwide Medical Insurance Data Analysis
por: Wei, Guoxu, et al.
Publicado: (2021)

Gabapentin for Off-Label Use: Evidence-Based or Cause for Concern?
por: Peckham, Alyssa M, et al.
Publicado: (2018)

The Ethics of Using Off-Label Medications to Treat COVID-19
por: Huffman, Alan
Publicado: (2022)

Recommendations on Off-Label Drug Use in Pediatric Guidelines
por: Meng, Min, et al.
Publicado: (2022)

On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients
por: Verbaanderd, Ciska, et al.
Publicado: (2020)

Physician Recruitment of Patients to Non-Therapeutic Oncology Clinical Trials: Ethics Revisited
por: Black, Lee, et al.
Publicado: (2013)

The Use of Risperidone in Behavioral and Psychological Symptoms of Dementia: A Review of Pharmacology, Clinical Evidence, Regulatory Approvals, and Off-Label Use
por: Yunusa, Ismaeel, et al.
Publicado: (2020)

Case Report: Off-label treatment of idiopathic hypereosinophilic syndrome with Omalizumab
por: Zhang, Zhiyu, et al.
Publicado: (2023)

Is Off-label repeat prescription of ketamine as a rapid antidepressant safe? Controversies, ethical concerns, and legal implications
por: Zhang, Melvyn W., et al.
Publicado: (2016)

Prescription Pattern and Off-Label Use of Antipsychotics in a Middle Eastern Population
por: Bastaki, Kholoud, et al.
Publicado: (2021)

Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline
por: Li, Guangyao, et al.
Publicado: (2022)

Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review
por: Fischler, Pascal Valentin, et al.
Publicado: (2022)

Utilisation of drugs for the treatment of psychiatric diseases in the pediatric population: focus on off-label use
por: Pesiou, Stella, et al.
Publicado: (2023)

Patient-reported outcomes labeling for oncology drugs: Multidisciplinary perspectives on current status and future directions
por: Cella, David, et al.
Publicado: (2022)

COVID-19 and off label use of drugs: an ethical viewpoint
por: Shojaei, Amirahmad, et al.
Publicado: (2020)

The Shared Ethical Responsibility of Medically and Non-medically Qualified Experts in Human Drug Development Teams
por: Kerpel-Fronius, Sandor, et al.
Publicado: (2018)

Real-World Prevalence of Direct Oral Anticoagulant Off-Label Doses in Atrial Fibrillation: An Epidemiological Meta-Analysis
por: Shen, Nan-Nan, et al.
Publicado: (2021)

A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study
por: Vitale, Antonio, et al.
Publicado: (2016)

Regulating off-label drug use in India: The arena for concern
por: Oberoi, Sukhvinder Singh
Publicado: (2015)

Development of the First Value Assessment Index System for Off-Label Use of Antineoplastic Agents in China: A Delphi Study
por: Jiang, Qian, et al.
Publicado: (2020)

Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database
por: Gozzo, Lucia, et al.
Publicado: (2021)

Ethical and legal framework and regulation for off-label use: European perspective
por: Lenk, Christian, et al.
Publicado: (2014)

Ethical use of off-label disease-modifying therapies for multiple sclerosis
por: Laurson-Doube, Joanna, et al.
Publicado: (2021)

Ethical review of off-label drugs during the COVID-19 pandemic
por: Li, Qiu-Yu, et al.
Publicado: (2022)

Safety of Anticancer Agents Used in Children: A Focus on Their Off-Label Use Through Data From the Spontaneous Reporting System
por: Mascolo, Annamaria, et al.
Publicado: (2020)

Off-label drug prescriptions in French general practice: a cross-sectional study
por: Drogou, François, et al.
Publicado: (2019)

Impact of Three Safety Interventions Targeting Off-Label Use of Immediate-Release Fentanyl on Prescription Trends: Interrupted Time Series Analysis
por: García-Sempere, Aníbal, et al.
Publicado: (2022)

New Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective
por: Sestito, Simona, et al.
Publicado: (2018)

Safety of Off-Label Pharmacological Treatment in Pediatric Neuropsychiatric Disorders: A Global Perspective From an Observational Study at an Italian Third Level Children’s Hospital
por: Giurin, Maria Sole, et al.
Publicado: (2022)

Ustekinumab trough levels in children with Crohn’s disease refractory to anti-tumor necrosis factor agents: a prospective case series of off-label use
por: Bouhuys, Marleen, et al.
Publicado: (2023)

Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?
por: Jauw, Yvonne W. S., et al.
Publicado: (2016)

Pediatric Off-Label COVID-19 Vaccination: The Concerns of Healthcare Professionals in Pakistan
por: Shakeel, Sadia, et al.
Publicado: (2022)

Examination of the Evidence for Off-Label Use of Gabapentin
por: Mack, Alicia
Publicado: (2003)

Neural text generation in regulatory medical writing
por: Meyer, Claudia, et al.
Publicado: (2023)

Screening Pregnant Women and Their Neonates for Illicit Drug Use: Consideration of the Integrated Technical, Medical, Ethical, Legal, and Social Issues
por: Price, Hayley R., et al.
Publicado: (2018)

Pharmacogenomics in oncology care
por: Filipski, Kelly K., et al.
Publicado: (2014)

A blueprint for success in real-world evidence: “glocal” approach to building capabilities and generating impactful evidence
por: Larsen, Kristoffer, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e7t1rdfhrvdhr8ja1pj166mo8k